Twitter - Protocol
Content of Tweets
The Patented Medicine Prices Review Board (PMPRB) Twitter account is used to advise users of new material posted to the PMPRB website. Tweets should not be considered as the authoritative source of new policy or guidance from the PMPRB. If you follow us, you can expect content covering some or all of the following:
- Announcements of Voluntary Compliance Undertakings, Board Decisions and Orders
- Notices of new publications including the NEWSletter and analytical studies
- Notices of consultations
- Conference presentations, speeches, news releases and other communication activities
- Notices of any changes to the website
- Other PMPRB updates including changes to policies, guidelines, services and initiatives
- Re-tweets of information of value to PMPRB Twitter followers
From time to time the PMPRB may retweet information that is of value to our Twitter followers. We may retweet news, links and other information that is relevant to the PMPRB's mandate.
These retweets are for convenience and information only. The PMPRB's decision to retweet does not imply endorsement on the part of the PMPRB and should not be taken as an explicit indication of any position or argument that may vary from the current official position, nor should it be taken as an indication of a possible shift in the PMPRB's current official position.
The PMPRB follows Government of Canada institutions and other organizations that we believe are relevant to the mandate of our work. This may include following Twitter accounts of non-profit organizations, patient advocacy associations, provincial and municipal governmental agencies, and companies and other commercial enterprises (and/or their employees) who comment on issues relating to patented medicines.
PMPRB's decision to follow a particular Twitter account does not imply endorsement of any kind.
Similarly, the appearance of a Twitter user as a follower of the PMPRB account does not imply endorsement. The PMPRB will only take steps to remove or block a follower if that follower does not abide by Twitter's terms of service.
Tweets will be posted simultaneously, but separately, in both official languages. If a tweet is meant to highlight a link to content found on the website, the language of the link will correspond to the language of the tweet.
A retweet will be delivered in the language of the original author with a translation provided if necessary.
We aim to update and monitor our Twitter account during regular office hours between 8:00 A.M. - 4 P.M. Eastern Standard Time, Monday to Friday.
Twitter may occasionally be unavailable and we accept no responsibility for lack of service owing to Twitter downtime.
@ Replies and Direct Messages
We welcome feedback and ideas from all our followers. However, we may not be able to reply individually to all the messages we receive via Twitter.
The other ways of contacting us for official correspondence are detailed in the Contact Us section of our website.
To protect your own privacy and the privacy of others, we recommend that you do not include personal information such as phone numbers or email addresses in the body of your replies or posts.
Media Requests and Complaints
We encourage you to follow traditional channels to make a media request or lodge a complaint.
The usual ways of contacting us for official correspondence are detailed in the Contact Us section of our website.
To make a formal complaint about the price of a patented medicine sold in Canada, go to the PMPRB webpage on How to Make a Complaint.
If you are looking for additional information about the PMPRB, please consult our website.
Other PMPRB Staff Tweeting
PMPRB staff may tweet under their own names or pseudonyms. Their tweets do not represent the official position of the PMPRB and should be considered the product of each individual as a private citizen.